Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Risperdal Consta Reimbursement Is Question Of “When, Not If” – Alkermes

Executive Summary

Alkermes is confident that Risperdal Consta will ultimately be reimbursed by all 50 state Medicaid programs
Advertisement

Related Content

Alkermes Seeking Partner For Long-Acting Alcoholism Agent Vivitrex
Alkermes Seeking Partner For Long-Acting Alcoholism Agent Vivitrex
Risperdal Consta Medicare Reimbursement Set At 95% Of AWP
Risperdal Consta Priced Aggressively; J&J Sets High Premium To Zyprexa
Risperdal Consta Priced Aggressively; J&J Sets High Premium To Zyprexa
Advertisement
UsernamePublicRestriction

Register

PS044088

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel